Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection

This publication has 24 references indexed in Scilit:

• Mucosal Immune System of the Human Genital Tract
  The Journal of Infectious Diseases, 1999
• Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection
  Vaccine, 1999
• Intranasal Immunization Is Superior to Vaginal, Gastric, or Rectal Immunization for the Induction of Systemic and Mucosal Anti-HIV Antibody Responses
  AIDS Research and Human Retroviruses, 1997
• A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease
  The Journal of Infectious Diseases, 1997
• DNA Immunization against Experimental Genital Herpes Simplex Virus Infection
  The Journal of Infectious Diseases, 1996
• Influenza immunization: intranasal live vaccinia recombinant contrasted with parenteral inactivated vaccine
  Vaccine, 1991
• In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020. II. Studies in Immunocompetent and Immunosuppressed Owl Monkeys (Aotus trivirgatus)
  The Journal of Infectious Diseases, 1990
• Antibody Response, Recurrence Patterns and Subsequent Herpes Simplex Virus Type 2 (HSV-2) Re-infection Following Initial HSV-2 Infection of Guinea-pigs: Effects of Acyclovir
  Journal of General Virology, 1986
• Vaccinia Virus Recombinant Expressing Herpes Simplex Virus Type 1 Glycoprotein D Prevents Latent Herpes in Mice
  Science, 1985
• Genital Herpes in Guinea Pigs: Pathogenesis of the Primary Infection and Description of Recurrent Disease
  The Journal of Infectious Diseases, 1982